PLOS Medicine publishes research and commentary of general interest with clear implications for patient care, public policy or clinical research agendas.
Contributed equally to this work with:
Jeffrey T.-J Huang,
F. Markus Leweke
Institute of Biotechnology, University of Cambridge, Cambridge, United Kingdom
Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany
Proteomics Research Group, Babraham Institute, Cambridge, United Kingdom
Ciphergen Biosystems Ltd., Surrey Research Park, Guildford, Surrey, United Kingdom
*To whom correspondence should be addressed. E-mail: firstname.lastname@example.org
This question is to determine if you're a human visitor in order to prevent automated spam
Your submission will be reviewed by our staff.
There was a problem with your submission. Please try again later.